SecBot SecBot
8-K ·Filed Sep 17, 2026

MEDS

DataMeds AI, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed1mo ago SEC0001493152-26-043169
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

The settlement removes a material overhang from the balance sheet and eliminates litigation risk. Watch the next 10-Q for the actual liability reduction and any impact on equity from the share repurchase.

DirectionBullish
Confidencemedium
Horizonweeks
Latest settled — T+20d
MEDS ▼ -30.05% at T+20d
LONG call ✗ call lost -30.05% · α vs SPY -30.26% · entry $3.76 → $2.63
Next anchor: T+60d in 6w
Latest observation: T+25 -51.49% FF3 residual α
Entry = T+0 close
Sep 17, 2026
via day close
T+1d
+11.17%
call +11.17% · α +9.62%
$4.18
settled 6w ago
T+5d
-17.29%
call -17.29% · α -18.56%
$3.11
settled 5w ago
T+20d
-30.05%
call -30.05% · α -30.26%
$2.63
settled 12d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

DataMeds AI, Inc. settled litigation with former MIPA counterparties, paying $450,000 total ($350,000 to repurchase and extinguish 364,099 shares, $100,000 for claim releases). The company anticipates extinguishing approximately $19 million in balance sheet liability as a result. Both Florida and Delaware actions will be dismissed with prejudice.

Key Facts

  • Paid $450,000 total settlement: $350,000 to repurchase 364,099 shares, $100,000 for claim releases
  • Anticipates extinguishing approximately $19 million in liability from its consolidated balance sheet
  • Both Florida and Delaware lawsuits dismissed with prejudice with mutual releases
  • Settlement resolves disputes under the May 11, 2023 Membership Interest Purchase Agreement

Financial Impact

Extinguishes ~$19M in balance sheet liability for a cash outlay of $450,000, a net balance sheet improvement of ~$18.55M

liabilityshare countlitigation expense

Risk Factors

  • The $19M liability extinguishment is an estimate and may differ when finalized
  • No financial details on the original MIPA obligations or the nature of the liability were disclosed

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-043169
Document: 0001493152-26-043169-index-headers.html0001493152-26-043169
Document: 0001493152-26-043169-index.html0001493152-26-043169
Document: 0001493152-26-043169.txt0001493152-26-043169
7 reports for MEDS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MEDS — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
BEARISH ★ 6/10
$2.15awaiting T+20—$2.19 (−1.86%)
Oct 20, 2026
6d ago
8-K
NEUTRAL ★ 4/10
$2.75awaiting T+20—$2.19 (−20.36%)
Oct 16, 2026
10d ago
8-K
MIXED ★ 6/10
$2.67awaiting T+20—$2.19 (−17.98%)
Oct 13, 2026
13d ago
8-K
MIXED ★ 5/10
$2.85awaiting T+20—$2.19 (−23.16%)
Sep 17, 2026
5w ago
8-K
BULLISH ★ 6/10
$3.76 $2.63▼ −30.05%▼ −30.26%$2.19 (−41.76%)
Sep 16, 2026
5w ago
8-K
NEUTRAL ★ 5/10
$4.64 $2.85▼ −38.58%▼ −39.78%$2.19 (−52.80%)
Aug 18, 2026
9w ago
8-K
BEARISH ★ 7/10
$1.38 $6.07▼ −339.86%▼ −341.60%$2.19 (−58.70%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (11h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 17, 2026